In the intestinal microenvironment, during CRC progression the c-kit ligand SCF and the alarmin IL-33 are both abnormally expressed and are considered biomarkers of poor prognosis for their pro-tumorigenic action [32–36]. The gene discussed is IL33; the disease is colorectal carcinoma.